Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression

Molecular Biology Reports

Volumn 36, Issue 8, 2009, Pages 2153-2163

  He, Song ^a   Zhang, Dechun ^a   Cheng, Fang ^b   Gong, Fanghong ^a   Guo, Yanan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cancer; DsRNA; MiRNA; RNA interference (RNAi); ShRNA; SiRNA; Therapeutics

Indexed keywords

FLUOROURACIL; PACLITAXEL; SMALL INTERFERING RNA;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RESEARCH; CELL SURVIVAL; DRUG BINDING; ELIMINATION REACTION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE THERAPY; HUMAN; METASTASIS; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA INTERFERENCE;

GENE EXPRESSION; GENE SILENCING; GENE THERAPY; HUMANS; MICRORNAS; NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 66849094252     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9429-7     Document Type: Review

References (117)

1. SR Lai LG Andrews TO Tollefsbol 2007 RNA interference using a plasmid construct expressing short-hairpin RNA Methods Mol Biol 405 31 37 10.1007/978-1-60327-070-0-4 1:CAS:528:DC%2BD1cXmsFOjsw%3D%3D 18369815
2. SM Elbashir J Harborth W Lendeckel A Yalcin K Weber T Tuschl 2001 Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 6836 494 498 10.1038/35078107 1:CAS:528:DC%2BD3MXkt1ejt7Y%3D 11373684 (Pubitemid 32494397)
3. Y Ma CY Chan ML He 2007 RNA interference and antiviral therapy World J Gastroenterol 13 39 5169 5179 1:CAS:528:DC%2BD2sXht1emtbzP 17876887
4. X Gao P Zhang 2007 Transgenic RNA interference in mice Physiology (Bethesda) 22 161 166 10.1152/physiol.00002.2007 1:CAS:528:DC%2BD2sXnvFOhsr0%3D
5. JE Carpenter JA Hutchinson W Jackson C Grose 2008 Egress of light particles among filopodia on the surface of Varicella-Zoster virus-infected cells J Virol 82 6 2821 2835 10.1128/JVI.01821-07 1:CAS:528:DC%2BD1cXjtVartLk%3D 18184710 (Pubitemid 351329173)
6. X Huang JY Wang X Lu 2008 Systems analysis of quantitative shRNA-library screens identifies regulators of cell adhesion BMC Syst Biol 2 49 10.1186/1752-0509-2-49 18549508 (Pubitemid 351943444)
7. CY Wu MS Wu EP Chiang CC Wu YJ Chen CJ Chen NH Chi GH Chen JT Lin 2007 Elevated plasma osteopontin associated with gastric cancer development, invasion and survival Gut 56 6 782 789 10.1136/gut.2006.109868 1:CAS:528: DC%2BD2sXoslKisLc%3D 17148500 (Pubitemid 46854191)
8. M Gong Z Lu G Fang J Bi X Xue 2008 A small interfering RNA targeting osteopontin as gastric cancer therapeutics Cancer Lett 272 148 159 10.1016/j.canlet.2008.07.004 1:CAS:528:DC%2BD1cXht1Knt77L 18694621
9. H Nakabayashi T Hashimoto Y Miyao KK Tjong J Chan T Tamaoki 1991 A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma Mol Cell Biol 11 12 5885 5893 1:CAS:528: DyaK38Xhs1Khuw%3D%3D 1719374
10. X Yang Y Zhang L Zhang L Zhang J Mao 2008 Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell Cancer Lett 271 2 281 293 10.1016/j.canlet.2008.06.017 1:CAS:528: DC%2BD1cXht1entLnL 18657899
11. AM Hunter EC LaCasse RG Korneluk 2007 The inhibitors of apoptosis (IAPs) as cancer targets Apoptosis 12 9 1543 1568 10.1007/s10495-007-0087-3 1:CAS:528:DC%2BD2sXotFWru7c%3D 17573556
12. S Danson E Dean C Dive M Ranson 2007 IAPs as a target for anticancer therapy Curr Cancer Drug Targets 7 8 785 794 10.2174/156800907783220471 1:CAS:528:DC%2BD1cXhsFOntr4%3D 18220537
13. EJ Dean M Ranson F Blackhall C Dive 2007 X-linked inhibitor of apoptosis protein as a therapeutic target Expert Opin Ther Targets 11 11 1459 1471 10.1517/14728222.11.11.1459 1:CAS:528:DC%2BD2sXht1amsbbM 18028010 (Pubitemid 350200481)
14. BP Eckelman GS Salvesen FL Scott 2006 Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family EMBO Rep 7 10 988 994 10.1038/sj.embor.7400795 1:CAS:528:DC%2BD28XhtVajtr7K 17016456 (Pubitemid 44480512)
15. Y Hu G Cherton-Horvat V Dragowska S Baird RG Korneluk JP Durkin LD Mayer EC LaCasse 2003 Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo Clin Cancer Res 9 7 2826 2836 1:CAS:528:DC%2BD3sXlt1yrsbw%3D 12855663
16. DC McManus CA Lefebvre G Cherton-Horvat M St-Jean ER Kandimalla S Agrawal SJ Morris JP Durkin EC Lacasse 2004 Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics Oncogene 23 49 8105 8117 10.1038/sj.onc.1207967 1:CAS:528:DC%2BD2cXoslSkt74%3D 15378029 (Pubitemid 39531851)
17. XF Yang CJ Wu S McLaughlin A Chillemi KS Wang C Canning EP Alyea P Kantoff RJ Soiffer G Dranoff J Ritz 2001 CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia Proc Natl Acad Sci USA 98 13 7492 7497 10.1073/pnas. 131590998 1:CAS:528:DC%2BD3MXkslWlsrk%3D 11416219 (Pubitemid 32567976)
18. Y Yan L Phan F Yang M Talpaz Y Yang Z Xiong B Ng NA Timchenko CJ Wu J Ritz H Wang XF Yang 2004 A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L J Immunol 172 1 651 660 1:CAS:528:DC%2BD3sXpvFegsL8%3D 14688378
19. Q Wang M Li Y Wang Y Zhang S Jin G Xie Z Liu S Wang H Zhang L Shen H Ge 2008 RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells Cancer Lett 269 1 127 138 10.1016/j.canlet.2008.04.035 1:CAS:528:DC%2BD1cXhtVagtrfO 18534745
20. AC Carrano E Eytan A Hershko M Pagano 1999 SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 4 193 199 10.1038/12013 1:CAS:528:DyaK1MXltlSjtr0%3D 10559916
21. M Shapira O Ben-Izhak S Linn B Futerman I Minkov DD Hershko 2005 The prognostic impact of the ubiquitin ligase subunits skp2 and Cks1 in colorectal carcinoma Cancer 103 7 1336 1346 10.1002/cncr.20917 1:CAS:528: DC%2BD2MXjtFamsbs%3D 15717322 (Pubitemid 40410727)
22. S Signoretti L Di Marcotullio A Richardson S Ramaswamy B Isaac M Rue F Monti M Loda M Pagano 2002 Oncogenic role of the ubiquitin ligase subunit skp2 in human breast cancer J Clin Invest 110 5 633 641 1:CAS:528: DC%2BD38Xmslyitrs%3D 12208864
23. W Wei NG Ayad Y Wan GJ Zhang MW Kirschner WG Kaelin Jr 2004 Degradation of the SCF component skp2 in cellcycle phase G1 by the anaphase-promoting complex Nature 428 6979 194 198 10.1038/nature02381 1:CAS:528: DC%2BD2cXhvFCls70%3D 15014503 (Pubitemid 38374317)
24. R Chiarle Y Fan R Piva H Boggino J Skolnik D Novero G Palestro C De Wolf-Peeters M Chilosi M Pagano G Inghirami 2002 S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase Am J Pathol 160 4 1457 1466 1:CAS:528:DC%2BD38XjsFGjt7g%3D 11943729
25. D Hershko G Bornstein O Ben-Izhak A Carrano M Pagano MM Krausz A Hershko 2001 Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas Cancer 91 9 1745 1751 10.1002/1097- 0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H 1:CAS:528: DC%2BD3MXjslKns7o%3D 11335900 (Pubitemid 32377961)
26. Q Li M Murphy J Ross C Sheehan JA Carlson 2004 skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship J Cutan Pathol 31 10 633 642 10.1111/j.0303-6987.2004.00243.x 15491322 (Pubitemid 39440843)
27. TA Masuda H Inoue H Sonoda S Mine Y Yoshikawa K Nakayama K Nakayama M Mori 2000 Clinical and biological significance of S-phase kinase-associated protein 2 (skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by skp2 overexpression, possibly via p27 proteolysis Cancer Res 62 13 3819 3825
28. F Jiang NP Caraway R Li RL Katz 2005 RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells Oncogene 24 21 3409 3418 10.1038/sj.onc.1208459 1:CAS:528:DC%2BD2MXktVKnuro%3D 15735730 (Pubitemid 40756242)
29. Y Katagiri Y Hozumi S Kondo 2006 Knockdown of skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo J Dermatol Sci 42 3 215 224 10.1016/j.jdermsci.2005.12.016 1:CAS:528:DC%2BD28XksFyntLo%3D 16504485
30. Y Kudo T Takata W Yasui I Ogawa M Miyauchi T Takekoshi E Tahara H Nikai 1998 Reduced expression of cyclindependent kinase inhibitor p27 is an indicator of malignant behavior of oral squamous cell carcinomas Cancer 83 12 2447 2455 10.1002/(SICI)1097-0142(19981215)83:12<2447::AID-CNCR7>3.0.CO;2-A 1:CAS:528:DyaK1MXlsFyrtg%3D%3D 9874448 (Pubitemid 29019562)
31. Y Kudo S Kitajima S Sato I Ogawa M Miyauchi T Takata 2002 Transfection of p27 Kip1 threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells Oncology 63 4 398 404 10.1159/000066222 1:CAS:528: DC%2BD38XosVKnt74%3D 12417796 (Pubitemid 36151534)
32. L Fang Q Hu Z Hua S Li W Dong 2008 Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2 Int J Oral Maxillofac Surg 37 9 847 852 10.1016/j.ijom.2008.05.017 18620845
33. Y Toh E Oki S Oda E Tokunaga S Ohno Y Maehara GL Nicolson K Sujimachi 1997 Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis Int J Cancer 74 4 459 463 10.1002/(SICI)1097- 0215(19970822)74:4<459::AID-IJC18>3.0.CO;2-4 1:CAS:528:DyaK2sXlslKit78%3D 9291440 (Pubitemid 27400170)
34. M Kidd IM Modlin SM Mane RL Camp G Eick I Latich 2006 The role of gene markers-NAP1L1, MAGE-D2, and MTA1- in definiting small-intestinal carcinoid neoplasia Ann Surg Oncol 13 2 253 262 10.1245/ASO.2006.12.011 16424981 (Pubitemid 43157421)
35. GD Paterno Y Li HA Luchman PJ Ryan LL Gillespie 1997 cDNA cloning of a novel, developmentally regulated immediate early gene activated by fibroblast growth factor and encoding a nuclear protein J Biol Chem 272 41 25591 25595 10.1074/jbc.272.41.25591 1:CAS:528:DyaK2sXms1CqtLk%3D 9325278 (Pubitemid 27438871)
36. Y Toh SD Pencil GL Nicolson 1994 A novel candidate metastasis-associated gene, Mta1, differently expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses J Biol Chem 269 37 22958 22963 1:CAS:528:DyaK2MXnsF2ntw%3D%3D 8083195
37. MD Hofer R Kuefer S Varambally H Li J Ma GI Shapiro JE Gschwend RE Hautmann MG Sanda K Giehl A Menke AM Chinnaiyan MA Rubin 2004 The role of metastasis-associated protein 1 in prostate cancer progression Cancer Res 64 3 825 829 10.1158/0008-5472.CAN-03-2755 1:CAS:528:DC%2BD2cXhtFCgtL0%3D 14871807 (Pubitemid 38176879)
38. H Iguchi G Imura Y Toh Y Ogata 2000 Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer Int J Oncol 16 6 1211 1214 1:CAS:528:DC%2BD3cXjvVWhs7k%3D 10811997
39. MD Martin SG Hilsenbeck SK Mohsin TA Hopp GM Clark CK Osborne DC Allred P O'Connell 2006 Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies Breast Cancer Res Treat 95 1 7 12 10.1007/s10549-005-9016-8 1:CAS:528:DC%2BD28XhtlGks7c%3D 16244788 (Pubitemid 43228076)
40. H Sasaki H Yukiue Y Kobayashi Y Nakashima M Kaji I Fukai M Kiriyama Y Yamakawa Y Fujii 2001 Expression of the MTA1 mRNA in thymoma patients Cancer Lett 174 2 159 163 10.1016/S0304-3835(01)00704-2 1:CAS:528:DC%2BD3MXnvFCktLk%3D 11689291 (Pubitemid 33022675)
41. H Sasaki S Moriyama Y Nakashima Y Kobayashi H Yukiue M Kaji I Fukai M Kiriyama Y Yamakawa Y Fujii 2002 Expression of the MTA1 mRNA in advanced lung cancer Lung Cancer 35 2 149 154 10.1016/S0169-5002(01)00329-4 11804687 (Pubitemid 34136092)
42. Y Toh H Kuwano M Mori GL Nicolson K Sugimachi 1999 Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas Br J Cancer 79 11-12 1723 1726 10.1038/sj.bjc.6690274 1:STN:280:DyaK1M3itFWhtg%3D%3D 10206283
43. N Dube ML Tremblay 2005 Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases from diabetes obesity to cell cycle and cancer Biochim Biophys Acta 1754 1-2 108 117 1:CAS:528:DC%2BD2MXhtlags7nM 16198645
44. AW Stoker 2005 Protein tyrosine phosphatases and signalling J Endocrinol 185 1 19 33 10.1677/joe.1.06069 1:CAS:528:DC%2BD2MXjslGgs70%3D 15817824 (Pubitemid 40585064)
45. LA Cohen JL Guan 2005 Mechanisms of focal adhesion kinase regulation Curr Cancer Drug Targets 5 8 629 643 10.2174/156800905774932798 1:CAS:528: DC%2BD2MXhtlegsbfK 16375667
46. M Mariotti S Castiglioni JA Maier 2006 Expression analysis and modulation by HIV-Tat of the tyrosine phosphatase HD-PTP J Cell Biochem 98 2 301 308 10.1002/jcb.20770 1:CAS:528:DC%2BD28Xkt1Gkur0%3D 16408268
47. M Mariotti S Castiglioni S Garcia-Manteiga S Beguinot JA Maier 2008 HD-PTP inhibits endothelial migration through its interaction with Src Int J Biochem Cell Biol 10.1016/j.biocel.2008.08.005 18762272
48. S Toyooka M Ouchida Y Jitsumori K Tsukuda A Sakai A Nakamura N Shimizu K Shimizu 2000 HD-PTP: a novel protein tyrosine phosphatase gene on human chromosome 3p21.3 Biochem Biophys Res Commun 278 3 671 678 10.1006/bbrc.2000. 3870 1:CAS:528:DC%2BD3cXotlaluro%3D 11095967
49. M Li ZF Zhang VE Reuter C Cordon-Cardo 1996 Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder Am J Pathol 149 1 229 235 1:CAS:528:DyaK28XkslKhsbg%3D 8686747
50. M Bernués C Casadevall MR Caballín R Miro MJ Ejarque G Chechile A Gelabert J Egozcue 1999 Study of allelic losses on 3p, 6q, and 17p in human urothelial cancer Cancer Genet Cytogenet 112 1 42 45 10.1016/S0165- 4608(98)00248-9 10432934 (Pubitemid 29425869)
51. M Mariotti S Castiglioni JA Maier 2009 Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP Cancer Lett 273 1 155 163 10.1016/j.canlet.2008.08.017 1:CAS:528:DC%2BD1cXhsVWnu7jO 18835089
52. EA McSherry S Donatello AM Hopkins S McDonnell 2007 Molecular basis of invasion in breast cancer Cell Mol Life Sci 64 24 3201 3218 10.1007/s00018-007- 7388-0 1:CAS:528:DC%2BD1cXmtVyltA%3D%3D 17957337
53. T Akiyoshi K Uchida S Tateyama 2004 Expression of bone morphogenetic protein-6 (BMP-6) and BMP receptors in myoepithelial cells of canine mammary gland tumors Vet Pathol 41 2 154 163 10.1354/vp.41-2-154 1:CAS:528: DC%2BD2cXivFylsLs%3D 15017029 (Pubitemid 38453189)
54. JH Clement J Sanger K Hoffken 1999 Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor Int J Cancer 80 2 250 256 10.1002/(SICI)1097-0215(19990118)80:2<250::AID-IJC14>3.0.CO;2-D 1:CAS:528:DyaK1MXhtlamtw%3D%3D 9935207 (Pubitemid 29001729)
55. J Dai J Keller J Zhang Y Lu Z Yao ET Keller 2005 Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bonemetastases through a dual mechanism Cancer Res 65 18 8274 8285 10.1158/0008-5472.CAN-05-1891 1:CAS:528:DC%2BD2MXhtVShsbjK 16166304 (Pubitemid 41330592)
56. S Hatakeyama YH Gao YO Nemoto H Kataoka M Satoh 1997 Expression of bone morphogenetic proteins of human neoplastic epithelial cells Biochem Mol Biol Int 42 3 497 505 1:CAS:528:DyaK2sXnt1aju7g%3D 9247707
57. A Kawabata K Okano K Uchida R Yamaguchi T Hayashi S Tateyama 2005 Co-localization of chondromodulin-I (ChM-I) and bone morphogenetic protein-6 (BMP-6) in myoepithelial cells of canine mammary tumors J Vet Med Sci 67 11 1097 1102 10.1292/jvms.67.1097 1:CAS:528:DC%2BD28Xks1KisA%3D%3D 16327219 (Pubitemid 41758217)
58. BG Thomas FC Hamdy 2000 Bone morphogenetic protein-6: potential mediator of osteoblastic metastases in prostate cancer Prostate Cancer Prostatic Dis 3 4 283 285 10.1038/sj.pcan.4500482 1:CAS:528:DC%2BD3MXht1Sit7w%3D 12497079
59. S Yang J Du Z Wang W Yuan Y Qiao M Zhang J Zhang S Gao J Yin B Sun T Zhu 2007 BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells BMC Cancer 7 211 10.1186/1471-2407-7-211 17997862 (Pubitemid 351188972)
60. M Zhang Q Wang W Yuan S Yang X Wang JD Yan J Du J Yin SY Gao BC Sun TH Zhu 2007 Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells J Steroid Biochem Mol Biol 105 1-5 91 97 10.1016/j.jsbmb.2007.01.002 1:CAS:528:DC%2BD2sXovFyiurg%3D 17574840 (Pubitemid 47211944)
61. A Eger K Aigner S Sonderegger B Dampier S Oehler M Schreiber G Berx A Cano H Beug R Foisner 2005 DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Oncogene 24 14 2375 2385 10.1038/sj.onc.1208429 1:CAS:528:DC%2BD2MXislClsLo%3D 15674322 (Pubitemid 40546696)
62. S Guaita I Puig C Franci M Garrido D Dominguez E Batlle E Sancho S Dedhar AG De Herreros J Baulida 2002 Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression J Biol Chem 277 42 39209 39216 10.1074/jbc.M206400200 1:CAS:528: DC%2BD38XnvVeisLc%3D 12161443 (Pubitemid 35190890)
63. T Ohira RM Gemmill K Ferguson S Kusy J Roche E Brambilla C Zeng A Baron L Bemis P Erickson E Wilder A Rustgi J Kitajewski E Gabrielson R Bremnes W Franklin 2003 WNT7a induces E-cadherin in lung cancer cells Proc Natl Acad Sci USA 100 18 10429 10434 10.1073/pnas.1734137100 1:CAS:528:DC%2BD3sXntFyns70%3D 12937339 (Pubitemid 37071895)
64. K Aigner B Dampier L Descovich M Mikula A Sultan M Schreiber W Mikulits T Brabletz D Strand P Obrist W Sommergruber N Schweifer A Wernitznig H Beug R Foisner A Eger 2007 The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity Oncogene 26 49 6979 6988 10.1038/sj.onc.1210508 1:CAS:528:DC%2BD2sXht1Wgt7rP 17486063 (Pubitemid 350014612)
65. HL Chua P Bhat-Nakshatri SE Clare A Morimiya S Badve H Nakshatri 2007 NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 Oncogene 26 5 711 724 10.1038/sj.onc.1209808 1:CAS:528: DC%2BD2sXhtFGmurs%3D 16862183 (Pubitemid 46204250)
66. G Nishimura I Manabe K Tsushima K Fujiu Y Oishi Y Imai K Maemura M Miyagishi Y Higashi H Kondoh 2006 DeltaEF1 mediates TGF-beta signaling in vascular smooth muscle cell differentiation Dev Cell 11 1 93 104 10.1016/j.devcel.2006.05.011 1:CAS:528:DC%2BD28XnsVWnt7s%3D 16824956 (Pubitemid 43960803)
67. M Kato J Zhang M Wang L Lanting H Yuan JJ Rossi R Natarajan 2007 MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors Proc Natl Acad Sci USA 104 9 3432 3437 10.1073/pnas.0611192104 1:CAS:528:DC%2BD2sXjtVWltLo%3D 17360662 (Pubitemid 46364176)
68. S Yang J Du Z Wang J Yan W Yuan J Zhang T Zhu 2008 Dual mechanism of δEF1 expression regulated by bone morphogenetic protein-6 in breast cancer Int J Biochem Cell Biol 10.1016/j.biocel.2008.08.030
69. R Wang B Li X Wang F Lin P Gao SY Cheng HZ Zhang 2008 Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line Auris Nasus Laryn 10.1016/j.anl.2008.08.006
70. EK Rowinsky 1997 The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 48 353 374 10.1146/annurev.med.48.1.353 1:CAS:528:DyaK2sXhtFOmsLs%3D 9046968 (Pubitemid 27101837)
71. ZQ Yuan RI Feldman GE Sussman D Coppola SV Nicosia JQ Cheng 2003 AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance J Biol Chem 278 26 23432 23440 10.1074/jbc.M302674200 1:CAS:528:DC%2BD3sXkslygsLY%3D 12697749 (Pubitemid 36830160)
72. GZ Cheng J Chan Q Wang W Zhang CD Sun LH Wang 2007 Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel Cancer Res 67 5 1979 1987 10.1158/0008-5472.CAN-06-1479 1:CAS:528:DC%2BD2sXit12qurY%3D 17332325 (Pubitemid 46424214)
73. H Xing Y Cao D Weng W Tao X Song W Wang L Meng G Xu J Zhou S Wang D Ma 2008 Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxelinduced apoptosis via inhibition of the p38 pathway Apoptosis 13 2 213 223 10.1007/s10495-007-0158-5 1:CAS:528:DC%2BD1cXht1SisLk%3D 18158623
74. D Weng X Song H Xing X Ma X Xia Y Weng J Zhou G Xu L Meng T Zhu S Wang D Ma 2009 Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells Cancer Lett 273 2 257 265 10.1016/j.canlet.2008.08.027 1:CAS:528:DC%2BD1cXhsV2gtbvO 18842333
75. AT Chan SF Leung RK Ngan PM Teo WH Lau WH Kwan EP Hui HY Yiu W Yeo FY Cheung KH Yu KW Chiu DT Chan TS Mok S Yau KT Yuen FK Mo MM Lai BB Ma MK Kam TW Leung PJ Johnson PH Choi BC Zee 2005 Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 7 536 539 1:CAS:528:DC%2BD2MXjtFalt78%3D 15812080
76. JC Lin JS Jan CY Hsu WM Liang RS Jiang WY Wang 2003 Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival J Clin Oncol 21 4 631 637 10.1200/JCO.2003.06.158 12586799 (Pubitemid 46621896)
77. J Wee EH Tan BC Tai HB Wong SS Leong T Tan ET Chua E Yang KM Lee KW Fong HS Tan KS Lee S Loong V Sethi EJ Chua D Machin 2005 Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 27 6730 6738 10.1200/JCO.2005.16.790 1:CAS:528:DC%2BD2MXhtFWqsLfK 16170180 (Pubitemid 46190268)
78. RM Mader M Müller GG Steger 1998 Resistance to 5-fluorouracil Gen Pharmacol 31 5 661 666 10.1016/S0306-3623(98)00191-8 1:CAS:528: DyaK1cXntVCrsrk%3D 9809460 (Pubitemid 28520040)
79. GJ Hannon 2002 RNA interference Nature 418 6894 244 251 10.1038/418244a 1:CAS:528:DC%2BD38XltFGmu7Y%3D 12110901 (Pubitemid 34773784)
80. L Liu LG Andrews TO Tollefsbol 2006 Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death Oncogene 25 31 4370 4375 10.1038/sj.onc.1209454 1:CAS:528:DC%2BD28XntVWksrk%3D 16501599 (Pubitemid 44100507)
81. MK Kang RH Kim SJ Kim FK Yip KH Shin GP Dimri R Christensen T Han NH Park 2007 Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival Br J Cancer 96 1 126 133 10.1038/sj.bjc.6603529 1:CAS:528:DC%2BD2sXis1KnsA%3D%3D 17179983 (Pubitemid 46094649)
82. L Qin X Zhang L Zhang Y Feng GX Weng MZ Li QL Kong CN Qian YX Zeng MS Zeng DF Liao LB Song 2008 Downregulation of BMI-1 enhances 5-fluorouracil- induced apoptosis in nasopharyngeal carcinoma cells Biochem Biophys Res Commun 371 3 531 535 10.1016/j.bbrc.2008.04.117 1:CAS:528:DC%2BD1cXmsVegs7c%3D 18452707
83. WJ Guo MS Zeng A Yadav LB Song BH Guo V Band GP Dimri 2007 Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and downregulating Akt activity in breast cancer cells Cancer Res 67 11 5083 5089 10.1158/0008-5472. CAN-06-4368 1:CAS:528:DC%2BD2sXmtVaisL4%3D 17545584 (Pubitemid 46997242)
84. JT Marques BR Williams 2005 Activation of the mammalian immune system by siRNAs Nat Biotechnol 23 11 1399 1405 10.1038/nbt1161 1:CAS:528: DC%2BD2MXhtFyis7jN 16273073 (Pubitemid 41679392)
85. M Sioud 2005 Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization J Mol Biol 348 5 1079 1090 10.1016/j.jmb.2005. 03.013 1:CAS:528:DC%2BD2MXjs1OgtL8%3D 15854645 (Pubitemid 40602367)
86. A Reynolds D Leake Q Boese S Scaringe WS Marshall A Khvorova 2004 Rational siRNA design for RNA interference Nat Biotechnol 22 3 326 330 10.1038/nbt936 1:CAS:528:DC%2BD2cXhs1Wms7o%3D 14758366 (Pubitemid 38295766)
87. DH Kim MA Behlke SD Rose MS Chang S Choi JJ Rossi 2005 Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy Nat Biotechnol 23 2 222 226 10.1038/nbt1051 1:CAS:528:DC%2BD2MXhtVGnu74%3D 15619617 (Pubitemid 40255333)
88. YL Chiu TM Rana 2002 RNAi in human cells: basic structural and functional features of small interfering RNA Mol Cell 10 3 549 561 10.1016/S1097-2765(02) 00652-4 1:CAS:528:DC%2BD38XnvFSlt7k%3D 12408823 (Pubitemid 35284173)
89. J Elmen H Thonberg K Ljungberg M Frieden M Westergaard Y Xu B Wahren Z Liang H Orum T Koch C Wahlestedt 2005 Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Res 33 1 439 447 10.1093/nar/gki193 1:CAS:528:DC%2BD2MXmsVymsA%3D%3D 15653644 (Pubitemid 40276964)
90. F Czauderna M Fechtner S Dames H Aygun A Klippel GJ Pronk K Giese J Kaufmann 2003 Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells Nucleic Acids Res 31 11 2705 2716 10.1093/nar/gkg393 1:CAS:528:DC%2BD3sXkt1Wqsbo%3D 12771196 (Pubitemid 37442115)
91. CR Allerson N Sioufi R Jarres TP Prakash N Naik A Berdeja L Wanders RH Griffey EE Swayze B Bhat 2005 Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA J Med Chem 48 4 901 904 10.1021/jm049167j 1:CAS:528:DC%2BD2MXkvFSqsA%3D%3D 15715458 (Pubitemid 40270434)
92. AL Jackson J Burchard D Leake A Reynolds J Schelter J Guo JM Johnson L Lim J Karpilow K Nichols W Marshall A Khvorova PS Linsley 2006 Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing RNA 12 7 1197 1205 10.1261/rna.30706 1:CAS:528:DC%2BD28Xms1Cquro%3D 16682562 (Pubitemid 43990545)
93. DA Braasch S Jensen Y Liu K Kaur K Arar MA White DR Corey 2003 RNA interference in mammalian cells by chemically-modified RNA Biochemistry 42 26 7967 7975 10.1021/bi0343774 1:CAS:528:DC%2BD3sXksVCiu7g%3D 12834349 (Pubitemid 36807714)
94. AH Hall J Wan EE Shaughnessy B Ramsay Shaw KA Alexander 2004 RNA interference using boranophosphate siRNAs: structure-activity relationships Nucleic Acids Res 32 20 5991 6000 10.1093/nar/gkh936 1:CAS:528: DC%2BD2cXhtVanurvI 15545637 (Pubitemid 40073994)
95. S Parrish J Fleenor S Xu C Mello A Fire 2000 Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference Mol Cell 6 5 1077 1087 10.1016/S1097-2765(00)00106-4 1:CAS:528:DC%2BD3cXosV2mtr0%3D 11106747
96. YL Chiu TM Rana 2003 siRNA function in RNAi: a chemical modification analysis RNA 9 9 1034 1048 10.1261/rna.5103703 1:CAS:528:DC%2BD3sXntFaqur8%3D 12923253 (Pubitemid 37093614)
97. C Lorenz P Hadwiger M John HP Vornlocher C Unverzagt 2004 Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells Bioorg Med Chem Lett 14 19 4975 4977 10.1016/j.bmcl.2004.07.018 1:CAS:528:DC%2BD2cXnt12rt7c%3D 15341962 (Pubitemid 39165605)
98. K Cheng Z Ye RV Guntaka RI Mahato 2006 Enhanced hepatic uptake and bioactivity of type alpha1(I) collagen gene promoterspecific triplex-forming oligonucleotides after conjugation with cholesterol J Pharmacol Exp Ther 317 2 797 805 10.1124/jpet.105.100347 1:CAS:528:DC%2BD28XktFamu7Y%3D 16452392
99. F Simeoni MC Morris F Heitz G Divita 2003 Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res 31 2717 2724 10.1093/nar/gkg385 1:CAS:528:DC%2BD3sXkt1Wqs7o%3D 12771197 (Pubitemid 37442116)
100. A Muratovska MR Eccles 2004 Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett 558 1-3 63 68 10.1016/S0014-5793(03)01505-9 1:CAS:528:DC%2BD2cXpsV2gtg%3D%3D 14759517 (Pubitemid 38167411)
101. R Ikeda K Iwashita T Sumizawa S Beppu S Tabata Y Tajitsu Y Shimamoto K Yoshida T Furukawa XF Che T Yamaguchi M Ushiyama A Miyawaki Y Takeda M Yamamoto HY Zhao Y Shibayama K Yamada S Akiyama 2008 Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells Exp Cell Res 314 16 3017 3026 10.1016/j.yexcr.2008.07.001 1:CAS:528:DC%2BD1cXhtFCktbnE 18671966
102. EP Christofakis H Miyazaki DS Rubink WA Yeudall 2008 Roles of CXCL8 in squamous cell carcinoma proliferation and migration Oral Oncol 44 10 920 926 10.1016/j.oraloncology.2007.12.002 1:CAS:528:DC%2BD1cXhtFekurvP 18282785
103. Z Duan G Zhu D Yang X Zhang Y Gao 2008 Molecular mechanism of Skp2 in promoting cervical cancer HeLa cell proliferation J Med Coll PLA 23 4 199 208 10.1016/S1000-1948(08)60043-X 1:CAS:528:DC%2BD1cXhtVOgtbvP
104. JR Lund M Paoloni I Kurzman M Padilla DJ Argyle 2008 Inhibition of canine telomerase in vitro and in vivo using RNAi: further development of a natural canine model for telomerase-based cancer therapies Vet J 177 2 192 197 10.1016/j.tvjl.2007.09.015 1:CAS:528:DC%2BD1cXnt1amur8%3D 17981480 (Pubitemid 351791597)
105. W Zhao Y Xu D Kong R Liu Z Zhang C Jin Z Zhang Y Xiu 2008 Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer Orol Oncol 10.1016/j.urolonc.2008. 05.003
106. D Jere CX Xu R Arote CH Yun MH Cho CS Cho 2008 Poly(β-amino ester) as a carrier for si/shRNA delivery in lung cancer cells Biomaterials 29 16 2535 2547 10.1016/j.biomaterials.2008.02.018 1:CAS:528:DC%2BD1cXjvFOgur0%3D 18316120
107. CJ Dougherty TE Ichim L Liu G Reznik WP Min A Ghochikyan MG Agadjanyan BN Reznik 2008 Selective apoptosis of breast cancer cells by siRNA targeting of BORIS Biochem Biophys Res Commun 370 1 109 112 10.1016/j.bbrc.2008.03.040 1:CAS:528:DC%2BD1cXks1Kisr8%3D 18355444
108. Z Zhang P Sun J Liu L Fu J Yan Y Liu L Yu X Wang Q Yan 2008 Suppression of FUT1/FUT4 expression by siRNA inhibits tumor growth Biochim Biophys Acta 1783 2 287 296 10.1016/j.bbamcr.2007.10.007 1:CAS:528:DC%2BD1cXoslWmtg%3D%3D 18023290
109. TM Numnum S Makhija B Lu M Wang A Rivera M Stoff-Khalili RD Alvarez ZB Zhu DT Curiel 2008 Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines Gynecol Oncol 108 1 34 41 1:CAS:528:DC%2BD1cXhtlShtw%3D%3D 18061250
110. G Kawasaki S Yanamoto I Yoshitomi S Yamada A Mizuno 2008 Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion Int J Oral Maxillofac Surg 37 11 1039 1046 10.1016/j.ijom.2008.05.020 1:STN:280:DC%2BD1cjisVejug%3D%3D 18640824
111. L Zhang W Chen X Li 2008 A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF-κB signaling pathways in bladder cancer cells FEBS Lett 582 13 1821 1828 10.1016/j.febslet.2008.04.046 1:CAS:528:DC%2BD1cXms1WitL8%3D 18472007
112. Y Wang J Yu Q Zhan 2008 BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness Biochem Biophys Res Commun 370 2 201 206 10.1016/j.bbrc.2008.03.031 1:CAS:528:DC%2BD1cXlslCqsb0%3D 18343216
113. S Hara K Nakashiro H Goda H Hamakawa 2008 Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells Biochem Biophys Res Commun 370 1 123 128 10.1016/j.bbrc.2008.03.042 1:CAS:528: DC%2BD1cXks1Kisrc%3D 18355439
114. X Liang X Yang Y Tang H Zhou X Liu L Xiao J Gao Z Mao 2008 RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells Oral Oncol 44 12 1172 1180 10.1016/j.oraloncology.2008.03.004 1:CAS:528:DC%2BD1cXhsVWhtr3F 18486529
115. Q Li M Wu H Wang G Xu T Zhu Y Zhang P Liu A Song C Gang Z Han J Zhou L Meng Y Lu S Wang D Ma 2008 Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells Cancer Lett 261 1 55 63 10.1016/j.canlet.2007.11.018 1:CAS:528:DC%2BD1cXhslentLc%3D 18155831
116. SC Liu JJ Yang KN Shao PJ Chueh 2008 RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac Biochem Biophys Res Commun 365 4 672 677 10.1016/j.bbrc.2007.11.025 1:CAS:528:DC%2BD2sXhsVCks7vE 18023414 (Pubitemid 350234843)
117. SY Park W Lee J Lee IS Kim 2008 Combination gene therapy using multidrug resistance (MDR1) gene shRNA and herpes simplex virus-thymidine kinase Cancer Lett 261 2 205 214 10.1016/j.canlet.2007.11.011 1:CAS:528:DC%2BD1cXitlemtLs%3D 18096314